Stock listing

NASDAQ:EQ Equillium, Inc. Stock

Home listing (NASDAQ) of Equillium, Inc.

Follow Equillium, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:EQ

$1.06 USD -0.04 (-3.6%)

Close on Nov 20, 2026

Past year +5.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.06 – $1.17 USDNov 20, 2026
Volume
567,889 sharesNov 20, 2026
Market cap
$87.26M USDAt the close on Nov 20, 2026 · price × 82.32M shares outstanding
52-week range
$0.812 – $3.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$894,985 USDMedian day 345,656 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Equillium, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:EQ · Home$1.06 USD-0.04 (-3.6%)567,889$1.12$1.17$1.055$1.10Close on Nov 20, 2026
LSE:0A4D$1.10 USD+0.02 (+1.9%)3,623$1.15$1.15$1.10$1.08Close on Nov 20, 2026
Frankfurt:0FY€1.005 EUR+0.073 (+7.8%)—€0.97€1.005€0.97€0.932Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:EQ · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.06-0.04-3.6%$1.12$1.17$1.055567,889
$1.10-0.11-9.1%$1.12$1.21$1.061889,903
$1.21+0.06+5.2%$1.15$1.24$1.15619,495
$1.15-0.14-10.9%$1.23$1.28$1.14570,708
$1.29-0.03-2.3%$1.36$1.36$1.27468,848
$1.32-0.10-7.0%$1.40$1.40$1.28163,581
$1.42-0.035-2.4%$1.47$1.50$1.41215,135
$1.455-0.045-3.0%$1.49$1.525$1.45157,300
$1.50-0.01-0.7%$1.52$1.61$1.49213,287
$1.51+0.18+13.5%$1.33$1.54$1.33218,504
$1.33-0.07-5.0%$1.38$1.42$1.25271,675
$1.40-0.01-0.7%$1.49$1.52$1.35194,697
$1.41+0.03+2.2%$1.38$1.455$1.36199,083
$1.38+0.01+0.7%$1.38$1.43$1.31337,696
$1.37-0.05-3.5%$1.38$1.42$1.29310,513
$1.420.000.0%$1.39$1.48$1.39283,928
$1.42+0.06+4.4%$1.40$1.43$1.36227,331
$1.36+0.11+8.8%$1.26$1.39$1.23345,656
$1.25+0.02+1.6%$1.20$1.25$1.17192,853
$1.23-0.04-3.1%$1.25$1.294$1.18315,632
$1.27-0.15-10.6%$1.40$1.42$1.23315,473
$1.42+0.04+2.9%$1.40$1.51$1.385442,539
$1.38+0.14+11.3%$1.25$1.43$1.24774,543
$1.24+0.05+4.2%$1.22$1.291$1.163,192,374
$1.19-0.13-9.8%$1.32$1.35$1.19466,800
$1.32+0.02+1.5%$1.30$1.38$1.28510,900
$1.30-0.02-1.5%$1.32$1.38$1.30263,700
$1.32-0.18-12.0%$1.50$1.50$1.32397,700
$1.50+0.09+6.4%$1.42$1.51$1.39383,500
$1.41-0.03-2.1%$1.45$1.46$1.38522,000
$1.44+0.05+3.6%$1.41$1.46$1.34645,000
$1.39-0.03-2.1%$1.41$1.43$1.35343,300
$1.42-0.03-2.1%$1.39$1.47$1.37393,500
$1.45+0.04+2.8%$1.37$1.46$1.30793,200
$1.41-0.13-8.4%$1.55$1.60$1.38933,800
$1.54-0.09-5.5%$1.67$1.67$1.53529,000
$1.63+0.01+0.6%$1.63$1.66$1.583,104,100
$1.62-0.06-3.6%$1.68$1.72$1.61316,100
$1.68+0.01+0.6%$1.65$1.72$1.63241,700
$1.67-0.05-2.9%$1.70$1.71$1.66137,800
$1.72-0.03-1.7%$1.72$1.74$1.65280,700
$1.75-0.18-9.3%$1.91$1.91$1.69504,500
$1.93+0.03+1.6%$1.90$1.95$1.813,071,700
$1.90-0.02-1.0%$1.98$1.98$1.85266,500
$1.92+0.03+1.6%$1.89$2.00$1.86853,500
$1.89+0.03+1.6%$1.90$1.95$1.80708,000
$1.86-0.19-9.3%$2.05$2.06$1.85769,700
$2.05-0.05-2.4%$2.09$2.09$2.01231,500
$2.10-0.01-0.5%$2.10$2.15$2.06261,500
$2.11-0.31-12.8%$2.46$2.46$2.11552,200
$2.42-0.14-5.5%$2.54$2.69$2.41397,300
$2.56+0.15+6.2%$2.41$2.56$2.331,085,400
$2.41+0.20+9.0%$2.20$2.47$2.17597,900
$2.21-0.01-0.5%$2.22$2.25$2.20225,900
$2.22-0.03-1.3%$2.26$2.31$2.18152,600
$2.25+0.04+1.8%$2.20$2.31$2.18101,200
$2.21-0.06-2.6%$2.25$2.26$2.19161,200
$2.27-0.12-5.0%$2.39$2.39$2.21289,000
$2.39-0.06-2.4%$2.46$2.46$2.33232,800
$2.45+0.09+3.8%$2.36$2.52$2.36364,000
$2.36+0.18+8.3%$2.18$2.47$2.15698,700
$2.18-0.02-0.9%$2.21$2.24$2.15606,000
$2.20-0.11-4.8%$2.31$2.31$2.18326,600
$2.31+0.04+1.8%$2.30$2.46$2.24557,300
$2.27-0.06-2.6%$2.27$2.33$2.21242,500
Ticker
NASDAQ:EQ
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Equillium, Inc. news

Equillium, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 140 in all · newest Nov 12, 2026 · oldest 2019
Decks
23 decks · latest May 27, 2026

Where Equillium, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:EQ · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:A2N7B3LS ExchangeGermanyEUR
gettex:0FYgettexGermanyEUR
BOATS:EQBOATSUnited StatesUSD
LSE:0A4DLSEUnited KingdomUSD
Lang & Schwarz:A2N7B3Lang & SchwarzGermanyEUR
Dusseldorf:0FYDusseldorfGermanyEUR
Frankfurt:0FYFrankfurtGermanyEUR
Munich:0FYMunichGermanyEUR
Stuttgart:0FYStuttgartGermanyEUR
Tradegate:0FYTradegateGermanyEUR

Valuation

Price/book 1.7× against a median of 2.9×: 4th lowest of 10 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$34.71M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.7×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.31

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Equillium, Inc. · NASDAQ:EQUS$87.26MUS$34.71Mn/an/an/a1.7×n/a0.0×1.31
Bio Solution Co., Ltd. · KRX:086820US$88.92MUS$80.23M137×6.2×n/a2.9×5.0%0.0×n/a
Infant Bacterial Therapeutics AB Class B · OMXSTO:IBT_BUS$88.36MUS$77.74Mn/an/an/a17.0×n/a0.0×n/a
Y-Biologics Inc. · KRX:338840US$88.10MUS$71.36Mn/a30.1×n/a6.8×n/a0.9×n/a
Cumberland Pharmaceuticals Inc. · NASDAQ:CPIXUS$87.57MUS$11.59M1.3×0.5×n/a1.2×273.7%0.1×0.72
Retension Pharmaceuticals, Inc. · NASDAQ:RTSNUS$87.57MUS$78.38Mn/an/an/an/an/an/an/a
Upstream Bio, Inc. · NASDAQ:UPBUS$87.15M−US$119.4Mn/a−41.6×n/a0.4×n/a0.0×1.95
Senhwa Biosciences Inc · TPEX:6492US$86.77MUS$67.44Mn/a2,117×n/a4.6×n/a0.0×n/a
Bioceltix SA · GPW:BCXUS$86.38MUS$72.43Mn/an/an/a5.6×n/a0.0×n/a
Perspective Therapeutics, Inc. · AMEX:CATXUS$86.05M−US$114.1Mn/a−570×n/a0.3×n/a0.0×1.47
Pharmosa Biopharm Inc. · TPEX:6875US$86.04MUS$62.27Mn/a38.5×n/a2.1×−658.1%0.1×n/a
Median of the othersUS$87.36MUS$69.40M69.1×6.2×2.9×5.0%0.0×1.47

Forecasts

8 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
8.56 USD · Analysts' mean
EPS, year to Dec 2026
-0.20 · 7 analysts

Team and board

Officers

OfficerRole
Bruce SteelChief Executive Officer
Stephen ConnellyPresident and Chief Scientific Officer
Christine ZedelmayerChief Operating Officer
Penny TomSVP Finance and Principal Accounting Officer
Snehal NaikChief Development Officer

Board

DirectorRole
Daniel BradburyChairman of the Board
Barbara TroupinDirector
Bruce SteelChief Executive Officer
Mark PruzanskiDirector
Martha DemskiDirector

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−2.3%
Q2 2026Aug 13, 2026 · After close+17.4%
Q1 2026May 13, 2026 · After close+12.1%
Q4 2025Mar 26, 2026−8.7%
Q3 2025Nov 13, 2025 · After close+23.8%
Q2 2025Aug 14, 2025 · After close+16.3%
Q1 2025May 14, 2025 · After close+4.5%
Q4 2024Mar 27, 2025−46.5%
Q3 2024Nov 13, 2024 · After close−12.3%
Q2 2024Aug 8, 2024 · After close−1.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−15.0%
Q4 2023Mar 25, 2024 · After close−15.6%
Q3 2023Nov 8, 2023 · After close−4.7%
Q2 2023Aug 9, 2023 · After close+3.9%
Q1 2023May 11, 2023 · After close+2.1%
Q4 2022Mar 23, 2023 · After close+11.5%
Q3 2022Nov 14, 2022 · After close+5.3%
Q2 2022Aug 15, 2022 · After close−1.2%
Q1 2022May 12, 2022 · After close+0.9%
Q4 2021Mar 23, 2022 · After close−0.3%

Open Events

Decks

DeckKindSlidesDate
Webinar: Insights into the Aryl Hydrocarbon Receptor and miR-124 Axis (May 2026)Conference46 slidesMay 27, 2026
Technical Presentation (November 2025)Technical58 slidesNov 5, 2025
Investor Presentation (August 2025)Investor deck43 slidesAugust 2025
Technical Presentation (March 2025)Technical17 slidesMar 27, 2025
Investor Presentation (November 2024)Investor deck51 slidesNovember 2024
Corporate Update (October 2024)Corporate update23 slidesOct 31, 2024
Technical Presentation (June 2024)Technical31 slidesJune 2024
Investor Day (October 2023)Investor day53 slidesOct 16, 2023
Investor Presentation (February 2023)Investor deck34 slidesFebruary 2023
Merger or Acquisition (December 2022)Merger or acquisition7 slidesDec 6, 2022
All 23 decks
DeckKindSlidesDate
Technical Presentation (November 2022)Technical23 slidesNov 3, 2022
Technical Presentation (September 2022)Technical32 slidesSep 27, 2022
Merger or Acquisition (September 2022)Merger or acquisition9 slidesSep 7, 2022
Merger or Acquisition (September 2022)Merger or acquisition9 slidesSep 6, 2022
Merger or Acquisition (February 2022)Merger or acquisition23 slidesFeb 16, 2022
Investor Presentation (March 2021)Investor deck40 slidesMar 9, 2021
Technical Presentation (February 2021)Technical14 slidesFeb 12, 2021
Investor Day (December 2020)Investor day114 slidesDec 4, 2020
Fact Sheet (October 2020)Fact sheet2 slidesOct 25, 2020
Investor Presentation (October 2019)Investor deck36 slidesOct 1, 2019
Investor Presentation (May 2019)Investor deck33 slidesMay 1, 2019
Investor Presentation (February 2019)Investor deck37 slidesFeb 26, 2019
Investor Presentation (November 2018)Investor deck30 slidesNov 13, 2018

Open Decks

Financings

RaiseDate
Private placement of shares of common stock and pre-funded warrants
Update: about US$20M · US$0.57 a share
Use of proceeds: Fund currently planned operations into 2029
Oct 26, 2026
Private placement of shares of common stock or pre-funded warrants
Announced: US$30M–US$50M · US$0.57 a share · Leerink Partners +1
Dealers: Leerink Partners (lead), LifeSci Capital
Buyers: ADAR1 Capital Management; Janus Henderson Investors; Adage Capital Partners LP; Coastlands Capital; Woodline Partners LP
Use of proceeds: Further development of EQ504, working capital and general corporate purposes
Aug 11, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$14.00 a share on Oct 11, 2018.

Price
US$14.00 a share
Shares offered
4,670,000 shares of common stock
Offering size
US$65.4 million
Underwriters
Jefferies, Leerink Partners, Stifel · In the order on the cover
Shares delivered
On or about Oct 16, 2018

Steps

StepWhen
Draft sent to the SEC in confidenceAug 3, 2018
Filed publiclySep 17, 2018
Amended twiceNewest Oct 2, 2018
Shares registered with an exchangeOct 5, 2018
Declared effective by the SECOct 11, 2018
Final prospectus, with the priceOct 12, 2018

Open IPO · From the cover of the final prospectus (424B4) filed Oct 12, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue130.0K41.1M36.1M15.8M00000
Cost of revenue116.0K137.0K126.0K118.0K72.0K45.0K23.0K6.10K122
Gross profit-116.0K41.1M36.1M15.8M-72.0K-45.0K-23.0K-6.10K-122
Research and development12.8M37.4M37.0M37.5M26.4M19.4M17.6M4.94M1.33M
Selling, general and administrative10.8M11.9M13.6M17.2M11.4M10.2M9.09M3.67M378.3K
Operating income-23.6M-8.27M-14.5M-62.1M-37.8M-29.5M-26.7M-8.62M-1.71M
Depreciation and amortization116.0K137.0K126.0K118.0K72.0K45.0K23.0K6.00K122
EBITDA-23.5M-8.13M-14.4M-62.0M-37.7M-29.5M-26.7M-8.61M-1.71M
Interest expense0491.0K1.05M1.07M1.10M279.0K2.56M379.4K
Income before tax-22.4M-7.71M-12.8M-62.4M-39.1M-29.8M-25.6M-13.3M-2.26M
Income tax0361.0K580.0K000-23.0K140.5K-2
Net income-22.4M-8.07M-13.3M-62.4M-39.1M-29.8M-25.6M-13.3M-2.26M
Earnings per share, basic-0.39-0.23-0.38-1.85-1.36-1.46-1.47-1.09-0.14
Earnings per share, diluted-0.39-0.23-0.38-1.85-1.36-1.46-1.47-1.09

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents30.3M18.1M23.2M59.1M50.4M24.0M13.2M28.5M7.10M
Short-term investments04.49M17.6M11.9M30.3M58.2M39.9M37.4M0
Receivables108.0K03.73M2.84M0
Current assets31.0M25.0M49.3M76.7M83.4M85.2M55.4M67.1M7.15M
Property, plant and equipment164.0K262.0K315.0K391.0K237.0K239.0K93.0K64.0K2.08K
Total assets31.9M25.6M50.5M78.4M85.4M85.4M55.5M67.2M7.15M
Accounts payable755.0K2.68M4.71M3.98M1.23M2.77M1.87M1.12M243.7K
Current liabilities2.93M6.36M27.6M32.0M8.91M7.25M3.88M2.03M568.8K
Long-term debt3.24M8.75M8.28M9.68M200.0K8.06M
Total debt719.0K384.0K824.0K9.07M10.2M9.94M9.68M200.0K16.1M
Total liabilities3.29M6.54M28.0M46.5M18.9M15.6M13.7M2.23M9.40M
Shareholders' equity28.6M19.1M22.6M31.9M66.5M69.9M41.8M64.9M-2.25M
Shares outstanding61.5M35.6M35.3M34.4M29.5M24.8M17.4M17.4M16.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-22.7M-19.0M-21.8M-8.73M-32.1M-24.6M-22.9M-7.53M-662.2K
Capital spending-48.0K-85.0K-50.0K-279.0K-57.0K-202.0K-74.0K-35.0K-2.20K
Free cash flow-22.8M-19.1M-21.8M-9.01M-32.1M-24.8M-23.0M-7.56M-664.4K
Cash from investing4.46M13.8M-4.76M18.7M27.4M-18.6M-2.17M-37.4M-2.20K
Cash from financing30.4M164.0K-9.23M-1.22M31.1M53.9M9.84M66.4M7.77M
Dividends paid-9.13M-9.88M
Share buybacks160.0K-260.0K01.15M53.9M-156.0K64.5M100
Change in cash12.2M-5.13M-35.9M8.74M26.4M10.8M-15.3M21.4M7.10M

Open Financials

Filings

FilingDateTypeFiled with
EFFECT · Notice that a registration is effectiveNov 20, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
S-3 · Registration statementNov 12, 2026Offer documentSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2026Big-stake noticeSEC
8-K · Current reportOct 26, 2026FinancingSEC
8-K · Current reportOct 5, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeAug 13, 2026Big-stake noticeSEC
8-K · Current reportAug 13, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
144 · Notice of proposed saleJun 5, 2026Other filingsSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
8-K · Current reportMay 29, 2026Meeting outcomeSEC
144 · Notice of proposed saleMay 27, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
8-K · Current reportMay 13, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeMay 7, 2026Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveApr 17, 2026Other filingsSEC
ARS · Annual report to shareholdersApr 15, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 15, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 15, 2026Meeting noticeSEC
CORRESP · Letter to the SECApr 14, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 13, 2026Other filingsSEC
S-3 · Registration statementApr 7, 2026Offer documentSEC
PRE 14A · Preliminary proxy statementMar 30, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveMar 26, 2026Other filingsSEC
S-8 · Registration statement for employee plansMar 25, 2026Offer documentSEC
10-K · Annual reportMar 25, 2026Annual reportSEC
8-K · Current reportMar 25, 2026ResultsSEC
CORRESP · Letter to the SECMar 23, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeMar 20, 2026Big-stake noticeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
8-K · Current reportMar 13, 2026Material contractSEC
4/A · Change in ownership, amendedMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
144 · Notice of proposed saleMar 9, 2026Other filingsSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 19, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
144 · Notice of proposed saleJan 8, 2026Other filingsSEC
4 · Change in ownershipDec 23, 2025Insider tradeSEC
144 · Notice of proposed saleDec 23, 2025Other filingsSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
144 · Notice of proposed saleDec 12, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeDec 8, 2025Big-stake noticeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
S-3 · Registration statementNov 13, 2025Offer documentSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeNov 13, 2025Big-stake noticeSEC
8-K/A · Current report, amendedOct 24, 2025Current reportSEC
8-K · Current reportOct 6, 2025Management or board changeSEC
8-K · Current reportSep 19, 2025Current reportSEC
424B5 · ProspectusSep 19, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 19, 2025Other filingsSEC
CORRESP · Letter to the SECSep 16, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 16, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 11, 2025Other filingsSEC
CORRESP · Letter to the SECSep 11, 2025Other filingsSEC
S-8 · Registration statement for employee plansSep 9, 2025Offer documentSEC
S-3 · Registration statementSep 9, 2025Offer documentSEC
UPLOAD · Letter from the SECSep 8, 2025Other filingsSEC
8-K · Current reportSep 4, 2025Current reportSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 11, 2025Material contractSEC
8-K · Current reportAug 4, 2025ResultsSEC
144 · Notice of proposed saleJul 8, 2025Other filingsSEC
8-K · Current reportJun 13, 2025Current reportSEC
144 · Notice of proposed saleJun 12, 2025Other filingsSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
8-K · Current reportMay 22, 2025Management or board changeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
DEFR14AApr 30, 2025Meeting noticeSEC
8-K · Current reportApr 24, 2025ResultsSEC
ARS · Annual report to shareholdersApr 10, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 10, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 10, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementMar 28, 2025Meeting noticeSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 27, 2025ResultsSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
8-K · Current reportFeb 6, 2025Current reportSEC
4 · Change in ownershipJan 24, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
8-K · Current reportDec 13, 2024Current reportSEC
4 · Change in ownershipDec 12, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 12, 2024Insider tradeSEC
8-K · Current reportDec 12, 2024Management or board changeSEC
4 · Change in ownershipNov 15, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 14, 2024Other filingsSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportNov 13, 2024ResultsSEC
144 · Notice of proposed saleOct 31, 2024Other filingsSEC
8-K · Current reportOct 31, 2024Current reportSEC
4 · Change in ownershipOct 30, 2024Insider tradeSEC
8-K · Current reportOct 30, 2024Current reportSEC
4 · Change in ownershipOct 29, 2024Insider tradeSEC
4 · Change in ownershipSep 27, 2024Insider tradeSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
8-K · Current reportJul 23, 2024Current reportSEC
4 · Change in ownershipJul 18, 2024Insider tradeSEC
8-K · Current reportJul 18, 2024ResultsSEC
144 · Notice of proposed saleJul 16, 2024Other filingsSEC
8-K · Current reportJun 4, 2024Current reportSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
8-K · Current reportMay 23, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
ARS · Annual report to shareholdersApr 11, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 11, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 11, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 1, 2024Meeting noticeSEC
8-K · Current reportApr 1, 2024Current reportSEC
S-8 · Registration statement for employee plansMar 25, 2024Offer documentSEC
10-K · Annual reportMar 25, 2024Annual reportSEC
8-K · Current reportMar 25, 2024ResultsSEC
3 · Initial statement of ownershipMar 8, 2024Insider tradeSEC
8-K · Current reportMar 8, 2024Management or board changeSEC
8-K · Current reportFeb 23, 2024ResultsSEC
424B5 · ProspectusFeb 23, 2024Offer documentSEC
8-K · Current reportFeb 22, 2024Current reportSEC
SC 13G · Big-stake noticeJan 19, 2024Big-stake noticeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
4 · Change in ownershipJan 3, 2024Insider tradeSEC
8-K · Current reportDec 21, 2023Current reportSEC
10-Q · Quarterly reportNov 8, 2023Quarterly reportSEC
8-K · Current reportNov 8, 2023ResultsSEC
8-K · Current reportOct 16, 2023Current reportSEC
8-K · Current reportOct 5, 2023Material contractSEC
424B5 · ProspectusOct 5, 2023Offer documentSEC
10-Q · Quarterly reportAug 9, 2023Quarterly reportSEC
8-K · Current reportAug 9, 2023ResultsSEC
8-K · Current reportMay 25, 2023Current reportSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
4 · Change in ownershipMay 23, 2023Insider tradeSEC
8-K · Current reportMay 23, 2023Meeting outcomeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC

This page holds 200 of 472 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Equillium, Inc.’s releases · as of Nov 10, 2026

Common shares
82,324,700
Fully diluted
82,324,700

Fully diluted

LineSharesAs of
Common shares82,324,700Nov 10, 2026

Share count over time

CountShares
Nov 10, 202682,324,700

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Janus Henderson6.49M7.9%US$10.6MSep 30, 2026
abrdn4.46M5.4%US$7.24MSep 30, 2026
Decheng Capital LLC4.45M5.4%US$7.23MSep 30, 2026
Woodline Partners LP3.5M4.3%US$5.69MSep 30, 2026
ADAR1 Capital Management, LLC3.45M4.2%US$5.6MSep 30, 2026
Affinity Asset Advisors, LLC2.61M3.2%US$4.25MSep 30, 2026
Bank of America2.6M3.2%US$4.23MSep 30, 2026
Vanguard2.34M2.8%US$3.79MSep 30, 2026
Ra Capital Management, L.P.2.32M2.8%US$3.77MSep 30, 2026
Eversept Partners, LP1.29M1.6%US$2.1MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Marshall Wace, LLP750K0.91%US$1.22MSep 30, 2026
Citadel592K0.72%US$963KSep 30, 2026
Exome Asset Management LLC553K0.67%US$899KSep 30, 2026
Adage Capital Partners Gp, L.L.C.524K0.64%US$852KSep 30, 2026
DG Capital Management, LLC480K0.58%US$780KSep 30, 2026
Geode Capital472K0.57%US$767KSep 30, 2026
Renaissance Technologies447K0.54%US$726KSep 30, 2026
Squarepoint Ops LLC348K0.42%US$566KSep 30, 2026
Ikarian Capital, LLC304K0.37%US$493KSep 30, 2026
BlackRock285K0.35%US$463KSep 30, 2026
Boothbay Fund Management, LLC284K0.35%US$462KSep 30, 2026
Susquehanna257K0.31%US$417KSep 30, 2026
Tudor Investment Corp Et Al243K0.30%US$395KSep 30, 2026
State Street198K0.24%US$322KSep 30, 2026
Acuta Capital Partners, LLC183K0.22%US$297KSep 30, 2026
Two Sigma141K0.17%US$230KSep 30, 2026
Integrated Quantitative Investments LLC126K0.15%US$205KSep 30, 2026
Northern Trust111K0.14%US$181KSep 30, 2026
Cantor Fitzgerald, L. P.109K0.13%US$177KSep 30, 2026
Soleus Capital Management, L.P.90,0000.11%US$146KSep 30, 2026
Quadrature Capital Ltd76,3220.09%US$124KSep 30, 2026
American Century75,4110.09%US$123KSep 30, 2026
China Universal Asset Management Co., Ltd.64,0000.08%US$104KSep 30, 2026
Jane Street57,3660.07%US$93,220Sep 30, 2026
Invesco53,2270.06%US$86,494Sep 30, 2026
AlphaCore Capital LLC52,3450.06%US$85,061Sep 30, 2026
XTX Topco Ltd44,8830.05%US$72,935Sep 30, 2026
UBS38,2410.05%US$62,142Sep 30, 2026
RBC37,1970.05%US$60,000Sep 30, 2026
Virtu Financial LLC36,1000.04%US$59,000Sep 30, 2026
Barclays35,0000.04%US$56,875Sep 30, 2026
Jefferies Financial Group Inc.34,1000.04%US$55,413Sep 30, 2026
Schonfeld Strategic Advisors LLC33,4370.04%US$54,334Sep 30, 2026
High Net Worth Advisory Group LLC33,2300.04%US$53,999Sep 30, 2026
Corient Private Wealth LP31,9360.04%US$51,896Sep 30, 2026
Qube Research & Technologies Ltd25,6950.03%US$41,754Sep 30, 2026
Millennium20,8190.03%US$33,831Sep 30, 2026
Hudson Bay Capital Management LP18,2600.02%US$29,673Sep 30, 2026
Gsa Capital Partners LLP17,2770.02%US$28,000Sep 30, 2026
Chung Wu Investment Group, LLC16,5000.02%US$26,813Sep 30, 2026

This page holds 50 of 64 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.4M1.7%US$4.49MJun 30, 2026
Vanguard Extended Market Index Fund344K0.42%US$1.1MJun 30, 2026
Fidelity Extended Market Index Fund165K0.20%US$477KMay 31, 2026
iShares Micro-Cap ETF148K0.18%US$473KJun 30, 2026
Fidelity Total Market Index Fund54,7200.07%US$159KMay 31, 2026
Fidelity Series Total Market Index Fund47,4650.06%US$138KMay 31, 2026
Fidelity Nasdaq Composite Index Fund36,6830.04%US$106KMay 31, 2026
Tiff Multi-Asset Fund31,3350.04%US$100KJun 30, 2026
Vanguard Balanced Index Fund24,9870.03%US$79,958Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund22,5000.03%US$72,000Jun 30, 2026
All 15 holders
HolderSharesOf the companyValueAs of
Avantis U.S. Small Cap Equity ETF10,6230.01%US$30,807May 31, 2026
1290 VT Micro Cap Portfolio9,8600.01%US$31,552Jun 30, 2026
U.S. Micro Cap Portfolio7,668<0.01%US$16,870Jul 31, 2026
Dimensional U.S. Small Cap ETF7,665<0.01%US$16,863Jul 31, 2026
Victory Extended Market Index Fund5,565<0.01%US$12,243Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Connelly Stephen
Officer: President and CSO
Sale30,975USD 2.94US$91,067Jun 5, 2026
Zedelmayer Christine
Officer: Sr. Vice President and COO
Sale14,584USD 2.93US$42,731Jun 5, 2026
Connelly Stephen
Officer: President and CSO
Sale200,000USD 3.16US$632KJun 4, 2026
Zedelmayer Christine
Officer: Sr. Vice President and COO
Sale55,604USD 2.70US$150KMay 28, 2026
Zedelmayer Christine
Officer: Sr. Vice President and COO
Sale200USD 2.71US$542May 28, 2026
Zedelmayer Christine
Officer: Sr. Vice President and COO
Sale30,208USD 2.98US$90,020May 28, 2026
Tom Penny
Officer: Principal Accounting Officer
Sale65,000USD 2.95US$192KMay 28, 2026
Zedelmayer Christine
Officer: Sr. Vice President and COO
Sale9,821USD 2.70US$26,517May 27, 2026

Big stakes

StakeStakeSharesDateFiling
Janus Henderson Group PLC9.99%6.08MJan 30, 2026Schedule 13G
Ra Capital Management, L.P.9.90%6.71MSep 30, 2026Schedule 13G
ADAR1 Capital Management, LLC9.90%6.6MMar 31, 2026Schedule 13G
Xiangmin Cui8.90%5.73MMar 31, 2026Schedule 13G
Aberdeen Group plc7.03%4.46MSep 30, 2026Schedule 13G
Adage Capital Management, L.P.5.93%3.97MSep 30, 2026Schedule 13G
Woodline Partners LP5.90%3.51MSep 30, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jason Keyes
Other companies: BlossomHill Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 6, 2026); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Sesen Bio Inc (Director · May 3, 2021 – Jun 22, 2022 · Past)
Chief Financial Officer · Dec 10, 2020 – Feb 14, 2025 · Past
Martha Demski
Other companies: Alpha Teknova, Inc. (Board Member · Since at least Aug 31, 2023); ADMA Biologics Inc (Director · Mar 6, 2023 – Mar 6, 2023 · Past); Chimerix Inc (Director · May 17, 2022 – Apr 21, 2025 · Past)
Director · Since at least May 24, 2022
Krishna R Polu
Other companies: Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past)
Chief Medical Officer · Oct 11, 2018 – Apr 22, 2020 · Past
Mark Pruzanski
Other companies: Intercept Pharmaceuticals Inc (Director · Apr 9, 2013 – Nov 8, 2023 · Past)
Director · Since at least Oct 11, 2018
Barbara TroupinDirector · Since at least Feb 24, 2022
Bruce SteelChief Executive Officer · Since at least Oct 26, 2026
Christine ZedelmayerChief Operating Officer · Since at least May 27, 2026
Daniel BradburyChairman of the Board · Since at least Nov 5, 2026
Penny TomSVP Finance and Principal Accounting Officer · Since at least May 29, 2026
Snehal NaikChief Development Officer · Since at least May 13, 2026
All 11 people
PersonSeat
Stephen ConnellyPresident and Chief Scientific Officer · Since at least Jun 5, 2026

Open People

Log in to ask 6ix AI your own questions about Equillium, Inc.